- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
According to this study, over the next five years the Neuromodulation Devices and Implantable Infusion Pumps market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Neuromodulation Devices and Implantable Infusion Pumps business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Neuromodulation Devices and Implantable Infusion Pumps market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Neuromodulation Devices and Implantable Infusion Pumps, covering the supply chain analysis, impact assessment to the Neuromodulation Devices and Implantable Infusion Pumps market size growth rate in several scenarios, and the measures to be undertaken by Neuromodulation Devices and Implantable Infusion Pumps companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Spinal Cord Stimulation
Deep Brain Stimulation
Sacral Nerve Stimulation
Vagal Nerve Stimulation
Gastric Stimulation
Transcranial magnetic Stimulation
Transcutaneous Electrical Stimulation
Other
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Parkinson's disease
Epilepsy
Pain
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Medtronic
Greatbatch Medical
Boston Scientific Corporation
Synapse Biomedical
Nevro Corporation
Abbott
Autonomic Technologies
Neuropace
Avery Biomedical
Cyberonics
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Neuromodulation Devices and Implantable Infusion Pumps consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Neuromodulation Devices and Implantable Infusion Pumps market by identifying its various subsegments.
Focuses on the key global Neuromodulation Devices and Implantable Infusion Pumps manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Neuromodulation Devices and Implantable Infusion Pumps with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Neuromodulation Devices and Implantable Infusion Pumps submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Neuromodulation Devices and Implantable Infusion Pumps Consumption 2015-2025
2.1.2 Neuromodulation Devices and Implantable Infusion Pumps Consumption CAGR by Region
2.2 Neuromodulation Devices and Implantable Infusion Pumps Segment by Type
2.2.1 Spinal Cord Stimulation
2.2.2 Deep Brain Stimulation
2.2.3 Sacral Nerve Stimulation
2.2.4 Vagal Nerve Stimulation
2.2.5 Gastric Stimulation
2.2.6 Transcranial magnetic Stimulation
2.2.7 Transcutaneous Electrical Stimulation
2.2.8 Other
2.3 Neuromodulation Devices and Implantable Infusion Pumps Consumption by Type
2.3.1 Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Market Share by Type (2015-2020)
2.3.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue and Market Share by Type (2015-2020)
2.3.3 Global Neuromodulation Devices and Implantable Infusion Pumps Sale Price by Type (2015-2020)
2.4 Neuromodulation Devices and Implantable Infusion Pumps Segment by Application
2.4.1 Parkinson's disease
2.4.2 Epilepsy
2.4.3 Pain
2.4.4 Other
2.5 Neuromodulation Devices and Implantable Infusion Pumps Consumption by Application
2.5.1 Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Market Share by Type (2015-2020)
2.5.2 Global Neuromodulation Devices and Implantable Infusion Pumps Value and Market Share by Type (2015-2020)
2.5.3 Global Neuromodulation Devices and Implantable Infusion Pumps Sale Price by Type (2015-2020)
3 Global Neuromodulation Devices and Implantable Infusion Pumps by Company
3.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Company
3.1.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Company (2018-2020)
3.1.2 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Company (2018-2020)
3.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Company
3.2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Company (2018-2020)
3.2.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Company (2018-2020)
3.3 Global Neuromodulation Devices and Implantable Infusion Pumps Sale Price by Company
3.4 Global Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Neuromodulation Devices and Implantable Infusion Pumps Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Neuromodulation Devices and Implantable Infusion Pumps by Regions
4.1 Neuromodulation Devices and Implantable Infusion Pumps by Regions
4.2 Americas Neuromodulation Devices and Implantable Infusion Pumps Consumption Growth
4.3 APAC Neuromodulation Devices and Implantable Infusion Pumps Consumption Growth
4.4 Europe Neuromodulation Devices and Implantable Infusion Pumps Consumption Growth
4.5 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Consumption Growth
5 Americas
5.1 Americas Neuromodulation Devices and Implantable Infusion Pumps Consumption by Countries
5.1.1 Americas Neuromodulation Devices and Implantable Infusion Pumps Consumption by Countries (2015-2020)
5.1.2 Americas Neuromodulation Devices and Implantable Infusion Pumps Value by Countries (2015-2020)
5.2 Americas Neuromodulation Devices and Implantable Infusion Pumps Consumption by Type
5.3 Americas Neuromodulation Devices and Implantable Infusion Pumps Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Neuromodulation Devices and Implantable Infusion Pumps Consumption by Regions
6.1.1 APAC Neuromodulation Devices and Implantable Infusion Pumps Consumption by Regions (2015-2020)
6.1.2 APAC Neuromodulation Devices and Implantable Infusion Pumps Value by Regions (2015-2020)
6.2 APAC Neuromodulation Devices and Implantable Infusion Pumps Consumption by Type
6.3 APAC Neuromodulation Devices and Implantable Infusion Pumps Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Neuromodulation Devices and Implantable Infusion Pumps by Countries
7.1.1 Europe Neuromodulation Devices and Implantable Infusion Pumps Consumption by Countries (2015-2020)
7.1.2 Europe Neuromodulation Devices and Implantable Infusion Pumps Value by Countries (2015-2020)
7.2 Europe Neuromodulation Devices and Implantable Infusion Pumps Consumption by Type
7.3 Europe Neuromodulation Devices and Implantable Infusion Pumps Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps by Countries
8.1.1 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Value by Countries (2015-2020)
8.2 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Consumption by Type
8.3 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Neuromodulation Devices and Implantable Infusion Pumps Distributors
10.3 Neuromodulation Devices and Implantable Infusion Pumps Customer
11 Global Neuromodulation Devices and Implantable Infusion Pumps Market Forecast
11.1 Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Forecast (2021-2025)
11.2 Global Neuromodulation Devices and Implantable Infusion Pumps Forecast by Regions
11.2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Forecast by Regions (2021-2025)
11.2.2 Global Neuromodulation Devices and Implantable Infusion Pumps Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Neuromodulation Devices and Implantable Infusion Pumps Forecast by Type
11.8 Global Neuromodulation Devices and Implantable Infusion Pumps Forecast by Application
12 Key Players Analysis
12.1 Medtronic
12.1.1 Company Information
12.1.2 Neuromodulation Devices and Implantable Infusion Pumps Product Offered
12.1.3 Medtronic Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Medtronic Latest Developments
12.2 Greatbatch Medical
12.2.1 Company Information
12.2.2 Neuromodulation Devices and Implantable Infusion Pumps Product Offered
12.2.3 Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Greatbatch Medical Latest Developments
12.3 Boston Scientific Corporation
12.3.1 Company Information
12.3.2 Neuromodulation Devices and Implantable Infusion Pumps Product Offered
12.3.3 Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Boston Scientific Corporation Latest Developments
12.4 Synapse Biomedical
12.4.1 Company Information
12.4.2 Neuromodulation Devices and Implantable Infusion Pumps Product Offered
12.4.3 Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Synapse Biomedical Latest Developments
12.5 Nevro Corporation
12.5.1 Company Information
12.5.2 Neuromodulation Devices and Implantable Infusion Pumps Product Offered
12.5.3 Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Nevro Corporation Latest Developments
12.6 Abbott
12.6.1 Company Information
12.6.2 Neuromodulation Devices and Implantable Infusion Pumps Product Offered
12.6.3 Abbott Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Abbott Latest Developments
12.7 Autonomic Technologies
12.7.1 Company Information
12.7.2 Neuromodulation Devices and Implantable Infusion Pumps Product Offered
12.7.3 Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Autonomic Technologies Latest Developments
12.8 Neuropace
12.8.1 Company Information
12.8.2 Neuromodulation Devices and Implantable Infusion Pumps Product Offered
12.8.3 Neuropace Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Neuropace Latest Developments
12.9 Avery Biomedical
12.9.1 Company Information
12.9.2 Neuromodulation Devices and Implantable Infusion Pumps Product Offered
12.9.3 Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Avery Biomedical Latest Developments
12.10 Cyberonics
12.10.1 Company Information
12.10.2 Neuromodulation Devices and Implantable Infusion Pumps Product Offered
12.10.3 Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Cyberonics Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Neuromodulation Devices and Implantable Infusion Pumps Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Spinal Cord Stimulation
Table 5. Major Players of Deep Brain Stimulation
Table 6. Major Players of Sacral Nerve Stimulation
Table 7. Major Players of Vagal Nerve Stimulation
Table 8. Major Players of Gastric Stimulation
Table 9. Major Players of Transcranial magnetic Stimulation
Table 10. Major Players of Transcutaneous Electrical Stimulation
Table 11. Major Players of Other
Table 12. Global Consumption Sales by Type (2015-2020)
Table 13. Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Market Share by Type (2015-2020)
Table 14. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Type (2015-2020) ($ million)
Table 15. Global Neuromodulation Devices and Implantable Infusion Pumps Value Market Share by Type (2015-2020) ($ Millions)
Table 16. Global Neuromodulation Devices and Implantable Infusion Pumps Sale Price by Type (2015-2020)
Table 17. Global Consumption Sales by Application (2015-2020)
Table 18. Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Market Share by Application (2015-2020)
Table 19. Global Neuromodulation Devices and Implantable Infusion Pumps Value by Application (2015-2020)
Table 20. Global Neuromodulation Devices and Implantable Infusion Pumps Value Market Share by Application (2015-2020)
Table 21. Global Neuromodulation Devices and Implantable Infusion Pumps Sale Price by Application (2015-2020)
Table 22. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Company (2017-2019) (K Units)
Table 23. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Company (2017-2019)
Table 24. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Company (2017-2019) ($ Millions)
Table 25. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Company (2017-2019)
Table 26. Global Neuromodulation Devices and Implantable Infusion Pumps Sale Price by Company (2017-2019)
Table 27. Global Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base Distribution and Sales Area by Manufacturers
Table 28. Players Neuromodulation Devices and Implantable Infusion Pumps Products Offered
Table 29. Neuromodulation Devices and Implantable Infusion Pumps Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 30. Global Neuromodulation Devices and Implantable Infusion Pumps Consumption by Regions 2015-2020 (K Units)
Table 31. Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Market Share by Regions 2015-2020
Table 32. Global Neuromodulation Devices and Implantable Infusion Pumps Value by Regions 2015-2020 ($ Millions)
Table 33. Global Neuromodulation Devices and Implantable Infusion Pumps Value Market Share by Regions 2015-2020
Table 34. Americas Neuromodulation Devices and Implantable Infusion Pumps Consumption by Countries (2015-2020) (K Units)
Table 35. Americas Neuromodulation Devices and Implantable Infusion Pumps Consumption Market Share by Countries (2015-2020)
Table 36. Americas Neuromodulation Devices and Implantable Infusion Pumps Value by Countries (2015-2020) ($ Millions)
Table 37. Americas Neuromodulation Devices and Implantable Infusion Pumps Value Market Share by Countries (2015-2020)
Table 38. Americas Neuromodulation Devices and Implantable Infusion Pumps Consumption by Type (2015-2020) (K Units)
Table 39. Americas Neuromodulation Devices and Implantable Infusion Pumps Consumption Market Share by Type (2015-2020)
Table 40. Americas Neuromodulation Devices and Implantable Infusion Pumps Consumption by Application (2015-2020) (K Units)
Table 41. Americas Neuromodulation Devices and Implantable Infusion Pumps Consumption Market Share by Application (2015-2020)
Table 42. APAC Neuromodulation Devices and Implantable Infusion Pumps Consumption by Countries (2015-2020) (K Units)
Table 43. APAC Neuromodulation Devices and Implantable Infusion Pumps Consumption Market Share by Countries (2015-2020)
Table 44. APAC Neuromodulation Devices and Implantable Infusion Pumps Value by Regions (2015-2020) ($ Millions)
Table 45. APAC Neuromodulation Devices and Implantable Infusion Pumps Value Market Share by Regions (2015-2020)
Table 46. APAC Neuromodulation Devices and Implantable Infusion Pumps Consumption by Type (2015-2020) (K Units)
Table 47. APAC Neuromodulation Devices and Implantable Infusion Pumps Consumption Market Share by Type (2015-2020)
Table 48. APAC Neuromodulation Devices and Implantable Infusion Pumps Consumption by Application (2015-2020) (K Units)
Table 49. APAC Neuromodulation Devices and Implantable Infusion Pumps Consumption Market Share by Application (2015-2020)
Table 50. Europe Neuromodulation Devices and Implantable Infusion Pumps Consumption by Countries (2015-2020) (K Units)
Table 51. Europe Neuromodulation Devices and Implantable Infusion Pumps Consumption Market Share by Countries (2015-2020)
Table 52. Europe Neuromodulation Devices and Implantable Infusion Pumps Value by Countries (2015-2020) ($ Millions)
Table 53. Europe Neuromodulation Devices and Implantable Infusion Pumps Value Market Share by Countries (2015-2020)
Table 54. Europe Neuromodulation Devices and Implantable Infusion Pumps Consumption by Type (2015-2020) (K Units)
Table 55. Europe Neuromodulation Devices and Implantable Infusion Pumps Consumption Market Share by Type (2015-2020)
Table 56. Europe Neuromodulation Devices and Implantable Infusion Pumps Consumption by Application (2015-2020) (K Units)
Table 57. Europe Neuromodulation Devices and Implantable Infusion Pumps Consumption Market Share by Application (2015-2020)
Table 58. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Consumption by Countries (2015-2020) (K Units)
Table 59. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Consumption Market Share by Countries (2015-2020)
Table 60. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Value by Countries (2015-2020) ($ Millions)
Table 61. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Value Market Share by Countries (2015-2020)
Table 62. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Consumption by Type (2015-2020) (K Units)
Table 63. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Consumption Market Share by Type (2015-2020)
Table 64. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Consumption by Application (2015-2020) (K Units)
Table 65. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Consumption Market Share by Application (2015-2020)
Table 66. Neuromodulation Devices and Implantable Infusion Pumps Distributors List
Table 67. Neuromodulation Devices and Implantable Infusion Pumps Customer List
Table 68. Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Forecast by Countries (2021-2025) (K Units)
Table 69. Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Market Forecast by Regions
Table 70. Global Neuromodulation Devices and Implantable Infusion Pumps Value Forecast by Countries (2021-2025) ($ Millions)
Table 71. Global Neuromodulation Devices and Implantable Infusion Pumps Value Market Share Forecast by Regions
Table 72. Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Forecast by Type (2021-2025) (K Units)
Table 73. Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Market Share Forecast by Type (2021-2025)
Table 74. Global Neuromodulation Devices and Implantable Infusion Pumps Value Forecast by Type (2021-2025) ($ Millions)
Table 75. Global Neuromodulation Devices and Implantable Infusion Pumps Value Market Share Forecast by Type (2021-2025)
Table 76. Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Forecast by Application (2021-2025) (K Units)
Table 77. Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Market Share Forecast by Application (2021-2025)
Table 78. Global Neuromodulation Devices and Implantable Infusion Pumps Value Forecast by Application (2021-2025) ($ Millions)
Table 79. Global Neuromodulation Devices and Implantable Infusion Pumps Value Market Share Forecast by Application (2021-2025)
Table 80. Medtronic Product Offered
Table 81. Medtronic Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 82. Medtronic Main Business
Table 83. Medtronic Latest Developments
Table 84. Medtronic Basic Information, Company Total Revenue (in $ million), Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 85. Greatbatch Medical Product Offered
Table 86. Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 87. Greatbatch Medical Main Business
Table 88. Greatbatch Medical Latest Developments
Table 89. Greatbatch Medical Basic Information, Company Total Revenue (in $ million), Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 90. Boston Scientific Corporation Product Offered
Table 91. Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 92. Boston Scientific Corporation Main Business
Table 93. Boston Scientific Corporation Latest Developments
Table 94. Boston Scientific Corporation Basic Information, Company Total Revenue (in $ million), Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 95. Synapse Biomedical Product Offered
Table 96. Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 97. Synapse Biomedical Main Business
Table 98. Synapse Biomedical Latest Developments
Table 99. Synapse Biomedical Basic Information, Company Total Revenue (in $ million), Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 100. Nevro Corporation Product Offered
Table 101. Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 102. Nevro Corporation Main Business
Table 103. Nevro Corporation Latest Developments
Table 104. Nevro Corporation Basic Information, Company Total Revenue (in $ million), Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 105. Abbott Product Offered
Table 106. Abbott Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 107. Abbott Main Business
Table 108. Abbott Latest Developments
Table 109. Abbott Basic Information, Company Total Revenue (in $ million), Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 110. Autonomic Technologies Product Offered
Table 111. Autonomic Technologies Basic Information, Company Total Revenue (in $ million), Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 112. Autonomic Technologies Main Business
Table 113. Autonomic Technologies Latest Developments
Table 114. Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 115. Neuropace Product Offered
Table 116. Neuropace Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 117. Neuropace Main Business
Table 118. Neuropace Latest Developments
Table 119. Neuropace Basic Information, Company Total Revenue (in $ million), Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 120. Avery Biomedical Product Offered
Table 121. Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 122. Avery Biomedical Main Business
Table 123. Avery Biomedical Latest Developments
Table 124. Avery Biomedical Basic Information, Company Total Revenue (in $ million), Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 125. Cyberonics Product Offered
Table 126. Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 127. Cyberonics Main Business
Table 128. Cyberonics Latest Developments
Table 129. Cyberonics Basic Information, Company Total Revenue (in $ million), Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Neuromodulation Devices and Implantable Infusion Pumps
Figure 2. Neuromodulation Devices and Implantable Infusion Pumps Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Neuromodulation Devices and Implantable Infusion Pumps Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Spinal Cord Stimulation
Figure 7. Product Picture of Deep Brain Stimulation
Figure 8. Product Picture of Sacral Nerve Stimulation
Figure 9. Product Picture of Vagal Nerve Stimulation
Figure 10. Product Picture of Gastric Stimulation
Figure 11. Product Picture of Transcranial magnetic Stimulation
Figure 12. Product Picture of Transcutaneous Electrical Stimulation
Figure 13. Product Picture of Other
Figure 14. Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Market Share by Type (2015-2020)
Figure 15. Global Neuromodulation Devices and Implantable Infusion Pumps Value Market Share by Type (2015-2020)
Figure 16. Neuromodulation Devices and Implantable Infusion Pumps Consumed in Parkinson's disease
Figure 17. Global Neuromodulation Devices and Implantable Infusion Pumps Market: Parkinson's disease (2015-2020) (K Units)
Figure 18. Global Neuromodulation Devices and Implantable Infusion Pumps Market: Parkinson's disease (2015-2020) ($ Millions)
Figure 19. Neuromodulation Devices and Implantable Infusion Pumps Consumed in Epilepsy
Figure 20. Global Neuromodulation Devices and Implantable Infusion Pumps Market: Epilepsy (2015-2020) (K Units)
Figure 21. Global Neuromodulation Devices and Implantable Infusion Pumps Market: Epilepsy (2015-2020) ($ Millions)
Figure 22. Neuromodulation Devices and Implantable Infusion Pumps Consumed in Pain
Figure 23. Global Neuromodulation Devices and Implantable Infusion Pumps Market: Pain (2015-2020) (K Units)
Figure 24. Global Neuromodulation Devices and Implantable Infusion Pumps Market: Pain (2015-2020) ($ Millions)
Figure 25. Neuromodulation Devices and Implantable Infusion Pumps Consumed in Other
Figure 26. Global Neuromodulation Devices and Implantable Infusion Pumps Market: Other (2015-2020) (K Units)
Figure 27. Global Neuromodulation Devices and Implantable Infusion Pumps Market: Other (2015-2020) ($ Millions)
Figure 28. Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Market Share by Application (2015-2020)
Figure 29. Global Neuromodulation Devices and Implantable Infusion Pumps Value Market Share by Application (2015-2020)
Figure 30. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Company in 2017
Figure 31. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Company in 2019
Figure 32. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Company in 2017
Figure 33. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Company in 2019
Figure 34. Global Neuromodulation Devices and Implantable Infusion Pumps Sale Price by Company in 2019
Figure 35. Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Market Share by Regions 2015-2020
Figure 36. Global Neuromodulation Devices and Implantable Infusion Pumps Value Market Share by Regions 2015-2020
Figure 37. Americas Neuromodulation Devices and Implantable Infusion Pumps Consumption 2015-2020 (K Units)
Figure 38. Americas Neuromodulation Devices and Implantable Infusion Pumps Value 2015-2020 ($ Millions)
Figure 39. APAC Neuromodulation Devices and Implantable Infusion Pumps Consumption 2015-2020 (K Units)
Figure 40. APAC Neuromodulation Devices and Implantable Infusion Pumps Value 2015-2020 ($ Millions)
Figure 41. Europe Neuromodulation Devices and Implantable Infusion Pumps Consumption 2015-2020 (K Units)
Figure 42. Europe Neuromodulation Devices and Implantable Infusion Pumps Value 2015-2020 ($ Millions)
Figure 43. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Consumption 2015-2020 (K Units)
Figure 44. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Value 2015-2020 ($ Millions)
Figure 45. Americas Neuromodulation Devices and Implantable Infusion Pumps Consumption Market Share by Countries in 2019
Figure 46. Americas Neuromodulation Devices and Implantable Infusion Pumps Value Market Share by Countries in 2019
Figure 47. Americas Neuromodulation Devices and Implantable Infusion Pumps Consumption Market Share by Type in 2019
Figure 48. Americas Neuromodulation Devices and Implantable Infusion Pumps Consumption Market Share by Application in 2019
Figure 49. United States Neuromodulation Devices and Implantable Infusion Pumps Consumption Growth 2015-2020 (K Units)
Figure 50. United States Neuromodulation Devices and Implantable Infusion Pumps Value Growth 2015-2020 ($ Millions)
Figure 51. Canada Neuromodulation Devices and Implantable Infusion Pumps Consumption Growth 2015-2020 (K Units)
Figure 52. Canada Neuromodulation Devices and Implantable Infusion Pumps Value Growth 2015-2020 ($ Millions)
Figure 53. Mexico Neuromodulation Devices and Implantable Infusion Pumps Consumption Growth 2015-2020 (K Units)
Figure 54. Mexico Neuromodulation Devices and Implantable Infusion Pumps Value Growth 2015-2020 ($ Millions)
Figure 55. APAC Neuromodulation Devices and Implantable Infusion Pumps Consumption Market Share by Countries in 2019
Figure 56. APAC Neuromodulation Devices and Implantable Infusion Pumps Value Market Share by Regions in 2019
Figure 57. APAC Neuromodulation Devices and Implantable Infusion Pumps Consumption Market Share by Type in 2019
Figure 58. APAC Neuromodulation Devices and Implantable Infusion Pumps Consumption Market Share by Application in 2019
Figure 59. China Neuromodulation Devices and Implantable Infusion Pumps Consumption Growth 2015-2020 (K Units)
Figure 60. China Neuromodulation Devices and Implantable Infusion Pumps Value Growth 2015-2020 ($ Millions)
Figure 61. Japan Neuromodulation Devices and Implantable Infusion Pumps Consumption Growth 2015-2020 (K Units)
Figure 62. Japan Neuromodulation Devices and Implantable Infusion Pumps Value Growth 2015-2020 ($ Millions)
Figure 63. Korea Neuromodulation Devices and Implantable Infusion Pumps Consumption Growth 2015-2020 (K Units)
Figure 64. Korea Neuromodulation Devices and Implantable Infusion Pumps Value Growth 2015-2020 ($ Millions)
Figure 65. Southeast Asia Neuromodulation Devices and Implantable Infusion Pumps Consumption Growth 2015-2020 (K Units)
Figure 66. Southeast Asia Neuromodulation Devices and Implantable Infusion Pumps Value Growth 2015-2020 ($ Millions)
Figure 67. India Neuromodulation Devices and Implantable Infusion Pumps Consumption Growth 2015-2020 (K Units)
Figure 68. India Neuromodulation Devices and Implantable Infusion Pumps Value Growth 2015-2020 ($ Millions)
Figure 69. Australia Neuromodulation Devices and Implantable Infusion Pumps Consumption Growth 2015-2020 (K Units)
Figure 70. Australia Neuromodulation Devices and Implantable Infusion Pumps Value Growth 2015-2020 ($ Millions)
Figure 71. Europe Neuromodulation Devices and Implantable Infusion Pumps Consumption Market Share by Countries in 2019
Figure 72. Europe Neuromodulation Devices and Implantable Infusion Pumps Value Market Share by Countries in 2019
Figure 73. Europe Neuromodulation Devices and Implantable Infusion Pumps Consumption Market Share by Type in 2019
Figure 74. Europe Neuromodulation Devices and Implantable Infusion Pumps Consumption Market Share by Application in 2019
Figure 75. Germany Neuromodulation Devices and Implantable Infusion Pumps Consumption Growth 2015-2020 (K Units)
Figure 76. Germany Neuromodulation Devices and Implantable Infusion Pumps Value Growth 2015-2020 ($ Millions)
Figure 77. France Neuromodulation Devices and Implantable Infusion Pumps Consumption Growth 2015-2020 (K Units)
Figure 78. France Neuromodulation Devices and Implantable Infusion Pumps Value Growth 2015-2020 ($ Millions)
Figure 79. UK Neuromodulation Devices and Implantable Infusion Pumps Consumption Growth 2015-2020 (K Units)
Figure 80. UK Neuromodulation Devices and Implantable Infusion Pumps Value Growth 2015-2020 ($ Millions)
Figure 81. Italy Neuromodulation Devices and Implantable Infusion Pumps Consumption Growth 2015-2020 (K Units)
Figure 82. Italy Neuromodulation Devices and Implantable Infusion Pumps Value Growth 2015-2020 ($ Millions)
Figure 83. Russia Neuromodulation Devices and Implantable Infusion Pumps Consumption Growth 2015-2020 (K Units)
Figure 84. Russia Neuromodulation Devices and Implantable Infusion Pumps Value Growth 2015-2020 ($ Millions)
Figure 85. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Consumption Market Share by Countries in 2019
Figure 86. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Value Market Share by Countries in 2019
Figure 87. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Consumption Market Share by Type in 2019
Figure 88. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Consumption Market Share by Application in 2019
Figure 89. Egypt Neuromodulation Devices and Implantable Infusion Pumps Consumption Growth 2015-2020 (K Units)
Figure 90. Egypt Neuromodulation Devices and Implantable Infusion Pumps Value Growth 2015-2020 ($ Millions)
Figure 91. South Africa Neuromodulation Devices and Implantable Infusion Pumps Consumption Growth 2015-2020 (K Units)
Figure 92. South Africa Neuromodulation Devices and Implantable Infusion Pumps Value Growth 2015-2020 ($ Millions)
Figure 93. Israel Neuromodulation Devices and Implantable Infusion Pumps Consumption Growth 2015-2020 (K Units)
Figure 94. Israel Neuromodulation Devices and Implantable Infusion Pumps Value Growth 2015-2020 ($ Millions)
Figure 95. Turkey Neuromodulation Devices and Implantable Infusion Pumps Consumption Growth 2015-2020 (K Units)
Figure 96. Turkey Neuromodulation Devices and Implantable Infusion Pumps Value Growth 2015-2020 ($ Millions)
Figure 97. GCC Countries Neuromodulation Devices and Implantable Infusion Pumps Consumption Growth 2015-2020 (K Units)
Figure 98. GCC Countries Neuromodulation Devices and Implantable Infusion Pumps Value Growth 2015-2020 ($ Millions)
Figure 99. Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 100. Global Neuromodulation Devices and Implantable Infusion Pumps Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 101. Americas Neuromodulation Devices and Implantable Infusion Pumps Consumption 2021-2025 (K Units)
Figure 102. Americas Neuromodulation Devices and Implantable Infusion Pumps Value 2021-2025 ($ Millions)
Figure 103. APAC Neuromodulation Devices and Implantable Infusion Pumps Consumption 2021-2025 (K Units)
Figure 104. APAC Neuromodulation Devices and Implantable Infusion Pumps Value 2021-2025 ($ Millions)
Figure 105. Europe Neuromodulation Devices and Implantable Infusion Pumps Consumption 2021-2025 (K Units)
Figure 106. Europe Neuromodulation Devices and Implantable Infusion Pumps Value 2021-2025 ($ Millions)
Figure 107. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Consumption 2021-2025 (K Units)
Figure 108. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Value 2021-2025 ($ Millions)
Figure 109. United States Neuromodulation Devices and Implantable Infusion Pumps Consumption 2021-2025 (K Units)
Figure 110. United States Neuromodulation Devices and Implantable Infusion Pumps Value 2021-2025 ($ Millions)
Figure 111. Canada Neuromodulation Devices and Implantable Infusion Pumps Consumption 2021-2025 (K Units)
Figure 112. Canada Neuromodulation Devices and Implantable Infusion Pumps Value 2021-2025 ($ Millions)
Figure 113. Mexico Neuromodulation Devices and Implantable Infusion Pumps Consumption 2021-2025 (K Units)
Figure 114. Mexico Neuromodulation Devices and Implantable Infusion Pumps Value 2021-2025 ($ Millions)
Figure 115. Brazil Neuromodulation Devices and Implantable Infusion Pumps Consumption 2021-2025 (K Units)
Figure 116. Brazil Neuromodulation Devices and Implantable Infusion Pumps Value 2021-2025 ($ Millions)
Figure 117. China Neuromodulation Devices and Implantable Infusion Pumps Consumption 2021-2025 (K Units)
Figure 118. China Neuromodulation Devices and Implantable Infusion Pumps Value 2021-2025 ($ Millions)
Figure 119. Japan Neuromodulation Devices and Implantable Infusion Pumps Consumption 2021-2025 (K Units)
Figure 120. Japan Neuromodulation Devices and Implantable Infusion Pumps Value 2021-2025 ($ Millions)
Figure 121. Korea Neuromodulation Devices and Implantable Infusion Pumps Consumption 2021-2025 (K Units)
Figure 122. Korea Neuromodulation Devices and Implantable Infusion Pumps Value 2021-2025 ($ Millions)
Figure 123. Southeast Asia Neuromodulation Devices and Implantable Infusion Pumps Consumption 2021-2025 (K Units)
Figure 124. Southeast Asia Neuromodulation Devices and Implantable Infusion Pumps Value 2021-2025 ($ Millions)
Figure 125. India Neuromodulation Devices and Implantable Infusion Pumps Consumption 2021-2025 (K Units)
Figure 126. India Neuromodulation Devices and Implantable Infusion Pumps Value 2021-2025 ($ Millions)
Figure 127. Australia Neuromodulation Devices and Implantable Infusion Pumps Consumption 2021-2025 (K Units)
Figure 128. Australia Neuromodulation Devices and Implantable Infusion Pumps Value 2021-2025 ($ Millions)
Figure 129. Germany Neuromodulation Devices and Implantable Infusion Pumps Consumption 2021-2025 (K Units)
Figure 130. Germany Neuromodulation Devices and Implantable Infusion Pumps Value 2021-2025 ($ Millions)
Figure 131. France Neuromodulation Devices and Implantable Infusion Pumps Consumption 2021-2025 (K Units)
Figure 132. France Neuromodulation Devices and Implantable Infusion Pumps Value 2021-2025 ($ Millions)
Figure 133. UK Neuromodulation Devices and Implantable Infusion Pumps Consumption 2021-2025 (K Units)
Figure 134. UK Neuromodulation Devices and Implantable Infusion Pumps Value 2021-2025 ($ Millions)
Figure 135. Italy Neuromodulation Devices and Implantable Infusion Pumps Consumption 2021-2025 (K Units)
Figure 136. Italy Neuromodulation Devices and Implantable Infusion Pumps Value 2021-2025 ($ Millions)
Figure 137. Russia Neuromodulation Devices and Implantable Infusion Pumps Consumption 2021-2025 (K Units)
Figure 138. Russia Neuromodulation Devices and Implantable Infusion Pumps Value 2021-2025 ($ Millions)
Figure 139. Spain Neuromodulation Devices and Implantable Infusion Pumps Consumption 2021-2025 (K Units)
Figure 140. Spain Neuromodulation Devices and Implantable Infusion Pumps Value 2021-2025 ($ Millions)
Figure 141. Egypt Neuromodulation Devices and Implantable Infusion Pumps Consumption 2021-2025 (K Units)
Figure 142. Egypt Neuromodulation Devices and Implantable Infusion Pumps Value 2021-2025 ($ Millions)
Figure 143. South Africa Neuromodulation Devices and Implantable Infusion Pumps Consumption 2021-2025 (K Units)
Figure 144. South Africa Neuromodulation Devices and Implantable Infusion Pumps Value 2021-2025 ($ Millions)
Figure 145. Israel Neuromodulation Devices and Implantable Infusion Pumps Consumption 2021-2025 (K Units)
Figure 146. Israel Neuromodulation Devices and Implantable Infusion Pumps Value 2021-2025 ($ Millions)
Figure 147. Turkey Neuromodulation Devices and Implantable Infusion Pumps Consumption 2021-2025 (K Units)
Figure 148. Turkey Neuromodulation Devices and Implantable Infusion Pumps Value 2021-2025 ($ Millions)
Figure 149. GCC Countries Neuromodulation Devices and Implantable Infusion Pumps Consumption 2021-2025 (K Units)
Figure 150. GCC Countries Neuromodulation Devices and Implantable Infusion Pumps Value 2021-2025 ($ Millions)
Figure 151. Medtronic Neuromodulation Devices and Implantable Infusion Pumps Market Share (2018-2020)
Figure 152. Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Market Share (2018-2020)
Figure 153. Boston Scientific Corporation Neuromodulation Devices an
Please feel free to write an email to us or to use our electronic ticketing system.
